Cargando…
Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations
BACKGROUND: Antibiotic innovation has dwindled to dangerously low levels in the past 30 years. Since resistance continues to evolve, this innovation deficit can have perilous consequences on patients. A number of new incentives have been suggested to stimulate greater antibacterial drug innovation....
Autores principales: | Årdal, Christine, Baraldi, Enrico, Theuretzbacher, Ursula, Outterson, Kevin, Plahte, Jens, Ciabuschi, Francesco, Røttingen, John-Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885303/ https://www.ncbi.nlm.nih.gov/pubmed/29632669 http://dx.doi.org/10.1186/s40545-018-0135-0 |
Ejemplares similares
-
An antibiotic’s journey from marketing authorization to use, Norway
por: Årdal, Christine, et al.
Publicado: (2017) -
Challenges and shortcomings of antibacterial discovery projects
por: Theuretzbacher, Ursula, et al.
Publicado: (2023) -
An assessment of the future impact of alternative technologies on antibiotics markets
por: Nwokoro, Ejike, et al.
Publicado: (2016) -
Linking Sustainable Use Policies to Novel Economic Incentives to Stimulate Antibiotic Research and Development
por: Theuretzbacher, Ursula, et al.
Publicado: (2017) -
The effect of generic market entry on antibiotic prescriptions in the United States
por: Kållberg, Cecilia, et al.
Publicado: (2021)